Sustaining Big Pharma Momentum in Biosimilars, Technology-driven Ventures Remain in the Race
![Interests Spike](https://www.blog.sathguru.com/healthcare/wp-content/uploads/2017/08/Sustaining-Big.png)
Populist Price Control Approach Prevails in Healthcare Access for Medical Devices
![Affordability](https://www.blog.sathguru.com/healthcare/wp-content/uploads/2017/08/Populist-Price.png)
Robust M&A Landscape Prevails in Pharma Contract Services
![Private Vaccines Market in India](https://www.blog.sathguru.com/healthcare/wp-content/uploads/2017/08/Robust-MA.png)
Gilead Jumps on Oncology Bandwagon Post Anti-infectives Success
![Home-Health](https://www.blog.sathguru.com/healthcare/wp-content/uploads/2017/08/Gilead-Jumps.png)
Celebration Month for USFDA Medical Device Approvals
![Home-Health](https://www.blog.sathguru.com/healthcare/wp-content/uploads/2017/08/fda.png)
Funding Issues Prevail in the Under-appraised Anti-Infectives Market
![Home-Health](https://www.blog.sathguru.com/healthcare/wp-content/uploads/2017/08/Funding-Issues.png)
SATHGURU IN THE NEWS
Express Healthcare:
GST Impact on different Healthcare Sectors
Medical Buyer:
Orthopedic Devices Market – At a Turning Point
EVENTS
Meet us at The MedTech Conference (September25-27, 2017), the leading global medical technology conference
MANDATES —ongoing assignments and partnering opportunities
- Buy side mandate – US generic opportunities
- Strategic investments – Leading Israeli CDMO with strong expertise in topical products
- Series A VC fund raising – Artificial Intelligence based digital health venture
- Business Plan – Medtech Translational Center, Specialty Veterinary Hospital
RECENT PUBLICATIONS
- Cold Chain Technologies: Transforming Food Supply Chains
- Embracing Innovation, Driving Growth Across Healthcare Continuum – “Making in India”
- The Make in India Imperative – Position Paper on Regulatory and Policy Changes required for Sustained Competitiveness of the Indian Vaccine Industry
- Indian Orthopedic Devices Market A $2.4 Bn Opportunity
- Biosimilars – How can we realize the $ 240 Bn Opportunity